Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

semaglutide (the active ingredient in Rybelsus) caused thyroid tumors in mice and rats. Animal studies don’t always predict what will happen in people. And no cases of thyroid cancer have been ...

In some cases, doctors may use the test to diagnose thyroid cancer, or other damage to the thyroid. However, the test is not entirely conclusive. According to the National Health Service (NHS ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient ... If you have conditions like kidney disease or a history of thyroid cancer, GLP-1 agonists may not be suitable ...

The type 2 diabetes medication, generically known as semaglutide, has received unprecedented ... for conditions ranging from heart disease to cancer to neurodegenerative diseases.

US doctors tracked 350,000 patients for the research. They said the risk of developing thyroid cancer was higher, but still low. Around 500,000 people in the UK now use the drugs, which have been ...

Thyroid cancer is cancer of the thyroid gland in the neck. Thyroid cancer affects women more often than men. It has a good prognosis. Risk factors include a family history of this cancer, radiation ...